Funded Tech Companies

InterVenn BioSciences

Wondering who provided funding to InterVenn BioSciences? Heritage Provider Network, SoftBank Group and Highside Capital Management invested in this healthcare IT company.

Company Overview

Contact Information

Company Background Information

Overview

InterVenn BioSciences aims to find solutions for the most challenging health problems. InterVenn's approach combines the analysis of glycoproteomics using mass spectrometry with data science and artificial intelligence to quickly identify potentially actionable and clinically relevant information for conditions including cancers, autoimmunity, fibrosis, and neurodegeneration.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

8/3/2021

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Aldo Carrascoso

        

Chief Information Officer

Randolph Barr

        

Chief Operating Officer

Erwin Estigarribia

        

Chief Scientific Officer

Klaus Lindpaintner

        

General Manager

Axel Kornerup

        

Vice President

Kaitlynn Moser

        

Vice President

Daniel Serie

        

Vice President

Ada Wong

        

VP - Bus. Development

Fadzhairi Jabar

        

VP - Bus. Development

John Leite

        

VP - General Counsel

Stephana Patton

        

VP - R & D

Xin Cong

        

VP - Regulatory Affairs

Katherine Dalao

        

Company Investors

• Heritage Provider Network
• SoftBank Group
• Highside Capital Management
• Amplify Partners
• Genoa Ventures (Jenny Rooke)
• Anzu Partners (David Michael)
• Irving Investors
• True Ventures
• Xeraya Capital
• Prado SV
• Boost VC

Browse more funded tech companies:

InterVene | Intervention Insights

Share this article

About Our VC & M&A Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary